150 related articles for article (PubMed ID: 36422671)
21. Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review.
Hsu CC; Li WY; Chu PY
Medicine (Baltimore); 2018 Mar; 97(11):e0095. PubMed ID: 29538201
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma.
Piao S; Ma J; Wang W; Liu Y; Zhang M; Chen H; Guo F; Zhang B; Guo F
Oral Oncol; 2013 Aug; 49(8):796-801. PubMed ID: 23664741
[TBL] [Abstract][Full Text] [Related]
23. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
Nagao T; Gaffey TA; Visscher DW; Kay PA; Minato H; Serizawa H; Lewis JE
Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
[TBL] [Abstract][Full Text] [Related]
24. Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.
Schmitt NC; Kang H; Sharma A
Oral Oncol; 2017 Nov; 74():40-48. PubMed ID: 29103750
[TBL] [Abstract][Full Text] [Related]
25. Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta-Analysis.
Williams CYK; Townson AT; Terry N; Schmitt NC; Sharma A
Laryngoscope; 2023 Mar; 133(3):476-484. PubMed ID: 35567387
[TBL] [Abstract][Full Text] [Related]
26. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
Qian K; Di L; Guo K; Zheng X; Ji Q; Wang Z
J Oral Maxillofac Surg; 2018 Jul; 76(7):1578-1586. PubMed ID: 29544756
[TBL] [Abstract][Full Text] [Related]
27. Clinical Prediction Nomograms to Assess Overall Survival and Disease-Specific Survival of Patients with Salivary Gland Adenoid Cystic Carcinoma.
Cai HS; Huang SJ; Liang JF; Zhu Y; Hou JS
Biomed Res Int; 2022; 2022():7894523. PubMed ID: 36072473
[TBL] [Abstract][Full Text] [Related]
28. The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.
Kusafuka K; Sato Y; Nakatani E; Baba S; Maeda M; Yamanegi K; Ueda K; Inagaki H; Otsuki Y; Kuroda N; Suzuki K; Iwai H; Imamura Y; Itakura J; Yamanaka S; Takahashi H; Ito I; Akashi T; Daa T; Hamada M; Yasuda M; Kawata R; Yamamoto H; Tachibana Y; Fukuoka J; Muramatsu A; Arai K; Suzuki M
Head Neck; 2022 Jun; 44(6):1430-1441. PubMed ID: 35352425
[TBL] [Abstract][Full Text] [Related]
29. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
31. Intraoral salivary duct carcinoma: a clinicopathological study of four cases and review of the literature.
Epivatianos A; Dimitrakopoulos J; Trigonidis G
Ann Dent; 1995; 54(1-2):36-40. PubMed ID: 8572543
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
[TBL] [Abstract][Full Text] [Related]
33. Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.
Schmitt NC; Sharma A; Gilbert MR; Kim S
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):795-8. PubMed ID: 26307577
[TBL] [Abstract][Full Text] [Related]
34. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
Masubuchi T; Tada Y; Maruya S; Osamura Y; Kamata SE; Miura K; Fushimi C; Takahashi H; Kawakita D; Kishimoto S; Nagao T
Int J Clin Oncol; 2015 Feb; 20(1):35-44. PubMed ID: 24553861
[TBL] [Abstract][Full Text] [Related]
36. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
[TBL] [Abstract][Full Text] [Related]
37. Anatomic extent of lymph node metastases as an independent prognosticator in node-positive major salivary gland carcinoma: A study of the US SEER database and a Chinese multicenter cohort.
Shi X; Liu XK; An CM; Wei WJ; Tao Y; Ji Y; Zhang Y; Han W; Xue JC; Huang NS; Ma B; Zhang CP; Yang X; Wang KJ; Liu QJ; Liu Y; Wang Y; Lei BW; Yu PC; Hu JQ; Lu ZW; Hu WP; Tian YX; Wang YL; Ji QH
Eur J Surg Oncol; 2019 Nov; 45(11):2143-2150. PubMed ID: 31253544
[TBL] [Abstract][Full Text] [Related]
38. Salivary duct carcinoma.
Hosal AS; Fan C; Barnes L; Myers EN
Otolaryngol Head Neck Surg; 2003 Dec; 129(6):720-5. PubMed ID: 14663441
[TBL] [Abstract][Full Text] [Related]
39. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
Ryu HJ; Koh YW; Yoon SO
Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
[TBL] [Abstract][Full Text] [Related]
40. A predictive nomogram for recurrence of carcinoma of the major salivary glands.
Ali S; Palmer FL; Yu C; DiLorenzo M; Shah JP; Kattan MW; Patel SG; Ganly I
JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):698-705. PubMed ID: 23788168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
